Sales of diuretic medicine in Australia have experienced notable fluctuations from 2013 to 2023. These sales demonstrated a significant increase in 2020 and 2021, with year-on-year growth rates of 13.87% and 14.29% respectively. However, growth substantially slowed to 2.05% in 2022 and further down to 1.81% in 2023. As of 2023, the sales stood at 50.7 million US dollars. Looking ahead, the sales are forecasted to show a slower yet steady growth rate with an average annual increase of approximately 0.58% over the following five years, reaching 52.9 million US dollars by 2028.
Future trends to watch for include potential regulatory changes, advances in pharmaceutical technology, and shifts in patient demographics that could impact the demand for diuretics. Additionally, emerging health issues and innovations in alternative treatments may influence market dynamics and growth rates.
